Notably, the clearance of insulin can be slowed inpatients with diabetic nephropathy/chronic kidney disease (CKD), necessitating doseadjustment of some insulin therapies, such as human insulin and IGlar, if renal functiondeteriorates, as discussed later (50-52). Here, INS is linked to chronic kidney disease.